3
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Low-Dose Carbon Monoxide Does Not Reduce Vasoconstriction in Isolated Rat Lungs

&
Pages 21-32 | Received 14 Oct 1994, Accepted 12 Jun 1995, Published online: 02 Jul 2009

References

  • Von Euler US, Liljestrand G. Observations on the pulmonary arterial blood pressure in the cat. Acta Physiol Scand. 1946; 12: 301–320
  • Voelkel NF. Mechanisms of hypoxic pulmonary vasoconstriction. Am Rev Respir Dis. 1986; 133: 1186–1195
  • Cutaia M, Rounds S. Hypoxic pulmonary vasoconstriction: physiologic significance, mechanism, and clinical relevance. Chest. 1990; 97: 706–718
  • Farrukh IS, Michael JR. Cellular mechanisms that control pulmonary vascular tone during hypoxia and normoxia: possible role of Ca2+ ATPases. Am Rev Respir Dis. 1992; 145: 1389–1397
  • Palmer R MJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524–526
  • Pison U, Lopez FA, Heidelmeyer CF, Rossaint R, Falke KJ. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange. J Appl Physiol. 1993; 74: 1287–1292
  • Ramos KS, Lin H, McGrath JJ. Modulation of cyclic guanosine monophosphate levels in cultured aortic smooth muscle cells by carbon monoxide. Biochem Pharmacol. 1989; 38: 1368–1370
  • Lin H, McGrath JJ. Carbon monoxide effects on calcium levels in vascular smooth muscle. Life Sci. 1988; 43: 1813–1816
  • Penney DG, Tucker A, Bambach GA. Heart and lung alterations in neonatal rats exposed to CO or high altitude. J Appl Physiol. 1992; 73: 1713–1719
  • Hunter C, Barber GR, Shaw JW, Clegg EG. Growth of the heart and lungs in hypoxic rodents: a model of human hypoxic disease. Clin Sci Mol Med. 1974; 46: 375–391
  • Kinsella JP, Abman SH. Inhalational nitric oxide therapy for persistent pulmonary hypertension of the newborn. Pediatrics 1993; 91: 997–998
  • Weitzberg E, Rudehill A, Lundberg JM. Nitric oxide inhalation attenuates pulmonary hypertension and improves gas exchange in endotoxin shock. Eur J Pharmacol. 1993; 233: 85–94
  • Tonz M, von Segesser LK, Turina M. Selective pulmonary vasodilation with inhaled nitric oxide. J Thorac Cardiovasc Surg. 1993; 105: 760–762
  • Frostell CG, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991; 83: 2038–2047
  • Rich GF, Roos CM, Anderson SM, Ulrich DC, Daugherty MO, John RA. Inhaled nitric oxide: dose response and the effects of blood in the isolated rat lung. J Appl Physiol. 1993; 75: 1278–1284
  • Schmidt H HH. NO, CO, and OH: endogenous soluble guanylyl cyclase-activating factors. FEBS Lett. 1992; 307: 102–107
  • Snyder SH. Nitric oxide: first in a new class of neurotransmitters?. Science 1992; 257: 494–496
  • Marshall C, Cooper DY, Marshall BE. Reduced availability of energy initiates pulmonary vasoconstriction. Proc Soc Exp Biol Med. 1988; 187: 282–286
  • Sylvester JT, McGowan C. The effects of agents that bind to cytochrome P-450 on hypoxid pulmonary vasoconstriction. Circ Res. 1978; 43: 429–437
  • Duke H, Killick E. Pulmonary vasomotor responses of isolated perfused cat lungs to anoxia. J Physiol. 1952; 117: 303–316
  • McGrath JJ, Smith DI. Response of rat coronary circulation to carbon monoxide and nitrogen hypoxia. Proc Soc Exp Biol Med. 1984; 177: 132–136
  • McFaul S, McGrath JJ. Studies on the mechanism of carbon monoxide-induced vasodilation in the isolated perfused rat heart. Toxicol Appl Pharmacol. 1987; 464–473
  • Lin H, McGrath JJ. Carbon monoxide effects on calcium levels in vascular smooth muscle. Life Sci. 1988; 43: 1813–1816
  • Lin H, McGrath JJ. Vasodilating effects of carbon monoxide. Drug Chem Toxicol. 1988; 11: 371–385
  • Clubb FJ, Penney DG, Bishop SP. Cardiomegaly in neonatal rats exposed to 500 ppm carbon monoxide. J Mol Cell Cardiol. 1989; 21: 945–955
  • Clubb FJ, Penney DG, Baylerian MS, Bishop SP. Cardiomegaly due to myocyte hyperplasia in perinatal rats exposed to 200 ppm carbon monoxide. J Mol Cell Cardiol. 1986; 18: 477–486
  • Bassett D JP, Fisher AB. Metabolic responses to carbon monoxide by isolated rat lungs. Am J Physiol. 1976; 230: 658–663
  • Goldbaum LR, Ramirez RG, Absalon K. What is the mechanism of carbon monoxide toxicity?. Aviat Space Environ Med. 1975; 46: 1289–1291
  • Penney DG. A review: hemodynamic response to carbon monoxide. Environ Health Perspect. 1988; 77: 121–1130
  • Dodds RG, Penney DG, Sutariya BB. Cardiovascular, metabolic, and neurologic effects of carbon monoxide and cyanide in the rat. Toxicol Lett. 1992; 61: 243–254
  • Trischmann U, Klockner U, Isenberg G, Utz J, Ullrich V. Carbon monoxide inhibits depolarization-induced Ca rise and increases cyclic GMP in visceral smooth muscle cells. Biochem Pharmacol. 1991; 41: 237–241
  • Utz J, Ullrich V. Carbon monoxide relaxes ileal smooth muscle through activation of guanylate cyclase. Biochem Pharmacol. 1991; 41: 1195–1201
  • McGrath JJ. Effects of altitude on endogenous carboxyhemoglobin levels. J Toxicol Environ Health 1992; 35: 127–133
  • Davies DG, McGrath JJ. Arterial blood gas status in rats exposed to chronic CO at low and high altitude. Respir Physiol. 1989; 75: 193–198
  • McGrath JJ. Cardiovascular effects of chronic carbon monoxide and high-altitude exposure. Res Rep Health Eff Inst. 1989; 1–23
  • Cooper R, McGrath JJ, Dooley S, Kopetzky MT. Chronic exposure to carbon monoxide at high altitude: effects on mean electrical axis. Physiol Behav. 1989; 46: 75–79
  • McGrath JJ. Carbon monoxide studies at high altitude. Neurosci Biobehav Rev. 1988; 12: 311–314
  • Voelkel NF, McMurtry IF, Reeves JT. Hypoxia impairs vasodilation in the lung. J Clin Invest. 1981; 67: 238–246
  • Eugenio FN, Silva E., Paiva T, Paiva A. Increased intracellular Na+ and depolarization favor angiotensin tachyphylaxis in rabbit aorta. Am Physiol. 1991; 260: H373–H378
  • Vicaut E, Hou M, Stucker O, Teisseire B. Arteriolar vasoconstriction and tachyphylaxis with intraarterial angiotensin II. Microvasc Res. 1989; 37: 28–41

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.